Evaluation of prognostic factors in long-term survival in patients with hepatocelluar carcinoma (HCC)
- Conditions
- C22.0Liver cell carcinoma
- Registration Number
- DRKS00008996
- Lead Sponsor
- niversitätsklinikum Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
All patients who were treated for HCC at the University Hospital of Freiburg
Exclusion Criteria
Patients with other tumors than HCC
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival
- Secondary Outcome Measures
Name Time Method Treatment of HCC in different stages of disease
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms influence long-term survival in hepatocellular carcinoma patients as studied in DRKS00008996?
How do prognostic factors in DRKS00008996 compare to standard-of-care outcomes for C22.0 liver cancer?
Which biomarkers are associated with improved prognosis in hepatocellular carcinoma according to DRKS00008996?
What adverse events are reported in DRKS00008996 observational study of hepatocellular carcinoma survival?
Are there combination therapies or competitor drugs relevant to the hepatocellular carcinoma factors studied in DRKS00008996?